UNSPSC 51292203: Irolapride

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JS492IR8Z6. European Medicines Agency schedules Irolapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08297MIG. Irolapride generally arises in the molecular formula C19H28N2O3.

UNSPSC 51292203 Irolapride, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity in the record — Seminole County, Florida's IFB60459723LAS, posted June 30, 2026 — solicits naloxone and safe drug deactivation systems, not irolapride, a pharmaceutical product used in veterinary and human medicine unrelated to opioid overdose reversal or harm-reduction equipment. The mismatch between the code's nominal scope and the actual goods being purchased suggests either a coding error in the state and local opportunity record or that the code does not reflect current buying patterns.

The Seminole County solicitation is the only recent opportunity visible in the source. That IFB, due July 26, 2023, seeks annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the county community health building in Sanford, Florida. The contract includes a two-year initial term with a one-year renewal option, fixed-fee pricing, and potential FEMA funding with associated federal compliance requirements. Given the absence of additional opportunities and the categorical mismatch between code and scope, this code shows little relevant recent activity for firms pursuing irolapride procurement contracts at the state and local level.